Avicenna Life Sci US Fund LP — Form D/A
Avicenna Life Sci US Fund LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-07-08. $207.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-07-08
- Form: D/A
- Accession: 0000902664-25-002933
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $207.0M
- Investors: 9
- Date of first sale: 2024-08-01
- Security types: equity, fund interests
- SEC file number: 021-518021
Issuer
- Name: Avicenna Life Sci US Fund LP
- CIK: 0002028627
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 750 LEXINGTON AVENUE, NEW YORK, NY, 10022
- Phone: (212) 317-7500
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| - Avicenna Life Sci Master GP LLC | Executive Officer | New York, NY |
| Raymond Debbane | Executive Officer | The Woodlands, TX |
| - Avicenna Management LP | Promoter | New York, NY |
| - Invus Financial Advisors, L.L.C. | Promoter | New York, NY |
| - The Invus Group, LLC | Promoter | New York, NY |
Other filings by this issuer (1)
More